de Bruijn E - Search Results

1

Cellular uptake of the tyrosine kinase inhibitors imatinib and AMN107 in gastrointestinal stromal tumor cell lines.

Prenen H, Guetens G, de Boeck G, Debiec-Rychter M, Manley P, Schoffski P, van Oosterom AT, de Bruijn E. Prenen H, et al. Among authors: de boeck g, de bruijn e. Pharmacology. 2006;77(1):11-6. doi: 10.1159/000091943. Epub 2006 Mar 8. Pharmacology. 2006. PMID: 16534250

2

Everolimus alters imatinib blood partition in favour of the erythrocyte.

Prenen H, Guetens G, De Boeck G, Highley M, van Oosterom AT, de Bruijn EA. Prenen H, et al. J Pharm Pharmacol. 2006 Aug;58(8):1063-6. doi: 10.1211/jpp.58.8.0006. J Pharm Pharmacol. 2006. PMID: 16872552

3

Simultaneous determination of AMN107 and Imatinib (Gleevec, Glivec, STI571) in cultured tumour cells using an isocratic high-performance liquid chromatography procedure with UV detection.

Guetens G, Prenen H, De Boeck G, van Oosterom A, Schöffski P, Highley M, de Bruijn EA. Guetens G, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 1;846(1-2):341-5. doi: 10.1016/j.jchromb.2006.08.004. Epub 2006 Sep 7. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 16962394

4

Differential protein expression profile in gastrointestinal stromal tumors.

Landuyt B, Prenen H, Debiec-Rychter M, Sciot R, de Bruijn EA, van Oosterom AT. Landuyt B, et al. Among authors: de bruijn ea. Amino Acids. 2004 Dec;27(3-4):335-7. doi: 10.1007/s00726-004-0140-2. Epub 2004 Nov 12. Amino Acids. 2004. PMID: 15549490

5

Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry.

Guetens G, De Boeck G, Highley M, Dumez H, Van Oosterom AT, de Bruijn EA. Guetens G, et al. J Chromatogr A. 2003 Dec 5;1020(1):27-34. doi: 10.1016/s0021-9673(03)00775-1. J Chromatogr A. 2003. PMID: 14661754

6

Unexpected interactions between nicotinamide and CPT-11 in a rhabdomyosarcoma tumor model.

Wildiers H, Ahmed B, Guetens G, De Boeck G, De Bruijn EA, Landuyt W, Van Oosterom AT. Wildiers H, et al. Anticancer Res. 2003 Sep-Oct;23(5A):4055-9. Anticancer Res. 2003. PMID: 14666718

7

Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps.

Burger H, van Tol H, Brok M, Wiemer EA, de Bruijn EA, Guetens G, de Boeck G, Sparreboom A, Verweij J, Nooter K. Burger H, et al. Cancer Biol Ther. 2005 Jul;4(7):747-52. doi: 10.4161/cbt.4.7.1826. Epub 2005 Jul 9. Cancer Biol Ther. 2005. PMID: 15970668

8

In vitro partition of docetaxel and gemcitabine in human volunteer blood: the influence of concentration and gender.

Dumez H, Guetens G, De Boeck G, Highley MS, de Bruijn EA, van Oosterom AT, Maes RA. Dumez H, et al. Anticancer Drugs. 2005 Sep;16(8):885-91. doi: 10.1097/01.cad.0000175585.24317.ca. Anticancer Drugs. 2005. PMID: 16096438

9

In vitro partition of irinotecan (CPT-11) in human volunteer blood: the influence of concentration, gender and smoking.

Dumez H, Guetens G, De Boeck G, Highley MS, de Bruijn EA, van Oosterom AT, Maes RA. Dumez H, et al. Anticancer Drugs. 2005 Sep;16(8):893-5. doi: 10.1097/01.cad.0000175584.86198.ac. Anticancer Drugs. 2005. PMID: 16096439

10

Imatinib (Gleevec, Glivec) tumour tissue analysis by measurement of sediment and by liquid chromatography tandem mass spectrometry.

Guetens G, Prenen H, De Boeck G, Highley M, de Wever I, van Oosterom AT, de Bruijn EA. Guetens G, et al. J Sep Sci. 2006 Feb;29(3):453-9. doi: 10.1002/jssc.200500349. J Sep Sci. 2006. PMID: 16544888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters